Mild brain stimulation added to exercise for chronic widespread pain
Official title: Unravelling the Epigenetic Mechanisms of Exercise-induced Pain in Chronic Widespread Pain: DNA Methylation Regulation of the Brain-derived Neurotrophic Factor Expression and Its Modulation by Transcranial Direct Current Stimulation
Run by Vrije Universiteit Brussel · NCT07212829 · Data updated 2026-11-12
This study will test whether adding mild brain stimulation (tDCS) during a short bout of aerobic exercise helps people with chronic widespread pain have less pain and fatigue afterward.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Vrije Universiteit Brussel Academic / other |
| Locations | 1 site (Jette) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | December 30, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT07212829 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with chronic widespread pain or fibromyalgia, BMI ≤ 35, widespread pain for ≥3 months, and stable medications for at least one month are ideal candidates.
✕Probably not a fit
People who cannot safely perform submaximal aerobic exercise, have contraindications to brain stimulation, or who do not meet the study's inclusion criteria are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a randomized crossover design, 60 people with chronic widespread pain and 60 healthy controls each complete two hospital sessions at least one week apart: 20 minutes of submaximal aerobic exercise paired with either active transcranial direct current stimulation (tDCS, 30 minutes) or sham tDCS. The order of active and sham sessions is randomized and balanced for each participant. Pain intensity, serum BDNF protein, and BDNF gene methylation will be measured before and after each session to link symptom changes with molecular responses. The study aims to determine whether tDCS alters post-exercise symptom flares and associated BDNF-related genetic or epigenetic markers.
Why it matters
Potential benefit: If successful, this approach could reduce exercise-induced pain flares and help people with chronic widespread pain stay more physically active.
How similar studies have gone: Previous tDCS studies in chronic pain have shown mixed but sometimes promising symptom reductions, while combining tDCS with exercise and tracking BDNF methylation is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients Participants in the patient group must meet all of the following criteria: 1. Diagnosis of chronic widespread pain (CWP) or fibromyalgia; 2. Age between 18 and 70 years old; 3. Body mass index (BMI) ≤ 35; 4. Widespread Pain Index (WPI) assessment: the WPI questionnaire (0-19 points) will be used to record the number and distribution of painful body sites. Participants will be classified as having CWP if pain is reported on both sides of the body, above and below the waist, and in the axial skeleton, with pain symptoms lasting ≥ 3 months; 5. Stable medication use for at least 1 month prior to study entry. Healthy control group Participants in the healthy control group must meet all of the following criteria: 1. Age between 18 and 70 years old; 2. Body mass index (BMI) ≤ 35; 3. No chronic conditions, such as chronic pain and diabetes. Exclusion Criteria: For both patients and healthy controls, participants will be excluded if they meet any of the following: 1. Current pregnancy or pregnancy within the past 12 months; 2. Contraindications for non-invasive brain stimulation (NIBS), in line with published safety guidelines; 3. History of neurological disorders, including epilepsy (personal or family history), traumatic brain injury, stroke, dementia, or Parkinson's disease; 4. Major medical conditions, including cancer, endocrine or metabolic disorders, urine, genital and cardiovascu-lar diseases (e.g., myocardial infarction, heart failure, arrhythmia, uncontrolled hypertension). 5. Substance abuse. 6. Presence of psychiatric disorders other than depression or anxiety.
Where it's running
-
Vub
Jette, Belgium Recruiting
Study contacts
- Study coordinator: Pain in Motion research group
- Email: huanyu.xiong@vub.be
- Phone: +32 497783956
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Awareness and Expression Therapy to reduce widespread pain in lupus
This program will test whether an online emotional-awareness therapy (EAET) can reduce chronic widespread pain and other symptoms in adults with lupus who have fibromyalgia.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Dietary strategies to help fibromyalgia in overweight or obese women
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
-
Isokinetic microdose exercise for women with fibromyalgia
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.